Proposal Brief
Industry
Pharmaceuticals
Sub Industry
Generic Pharmaceuticals
Deal Size
INR 100 - 500 Cr
Preferred Location
India
Region
Across India
Looking to acquire
B2B, B2C Manufacturing businesses (Own Brand & Contract Manufacturing)
Open for Distressed Assets
No
Minimum Revenue
INR 50 Cr
Target Requirement
Description of buyer : leading India-based pharmaceutical company which offers a portfolio of products and services, including APIs, CPS, generics, biosimilars and
differentiated formulations.
Target areas of acquisition : Active Pharmaceutical Ingredients (APIs), Over-the-counter drugs (OTC), generics, biosimilars, and differentiated formulations. Entry level acquisition in OTC Products, branded generics in key therapeutic areas
Focus areas : Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynecology
Reason for acquisition : India is a global leader in the production of generic drugs. With many patents of branded drugs expiring, Indian pharmaceutical companies have the
opportunity to capture a larger market share by offering affordable generic alternatives, both domestically and internationally